Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Glucagon (AMG504-1) for Hypoglycemia in T1D
NCT02171130Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of glucagon in hypoglycemia, sponsored by Eli Lilly and Company. Started May 2014; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02171130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171130.